There were no significant differences between the immunohistochemical scores for E-cadherin with regard to the clinicopathological features, including lymph node metastasis, the size of the tumor, patient gender or histological grade of the tumor (Table 1). The gene discussed is CDH1; the disease is metastatic malignant neoplasm in the lymph nodes.